Price Regulation in the European Pharmaceutical Industry: Benefits and Costs

Horst-Manfred Schellhaass and Ulrich Stumpf

Chapter 8 in Economic Analysis of Regulated Markets, 1983, pp 151-167 from Palgrave Macmillan

Abstract: Abstract Currently, three approaches to drug pricing may be identified in EEC countries:2 relying on market forces (West Germany, the Netherlands and Denmark), regulating profits (UK) and regulating individual drug prices (France, Italy, Belgium/Luxemburg, Greece and Ireland3).

Keywords: National Health Service; Transfer Price; Price Regulation; Price Control; Profit Rate (search for similar items in EconPapers)
Date: 1983
References: Add references at CitEc
Citations: View citations in EconPapers (1)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-1-349-17099-9_8

Ordering information: This item can be ordered from
http://www.palgrave.com/9781349170999

DOI: 10.1007/978-1-349-17099-9_8

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().